Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive

With a new CEO prepared to take the reins next month and three key launches on deck for 2026 and 2027, Takeda is ready to shake off the generic-related declines that have plagued revenues in recent | Takeda's multiyear slim-down is expected to hit about 4,500 roles during the 2026 fiscal year, resulting in about 170 billion Japanese yen ($1.07 billion) in restructuring costs and some 100 billion yen ($633 million) in gross savings for 2026.

Raccontata dafiercepharma.comendpoints.newssiliconrepublic.combiopharmadive.com